Physician profile
Robert A Allen
NPI 1346376845
$823.66
in general payments reported to CMS, 2019-2025
16 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Dermatopathology (Dermatology) provider received nationally (typical 2025 total: $251).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $287 · 2024: $220 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.67 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.53 | 2023-2025 | Rinvoq |
| Janssen Biotech, INC. | $117.71 | 2023-2024 | Tremfya |
| Ucb, INC. | $85.43 | 2023-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $81.56 | 2023-2025 | |
| Lilly USA, LLC | $70.90 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $66.93 | 2023-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $47.03 | 2023-2024 | Zoryve |
| Amgen INC. | $35.13 | 2023-2025 | Otezla, Otezla |
| Genzyme Corporation | $34.36 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $32.77 | 2024-2025 | Dupixent |
| Organon LLC | $26.20 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $18.58 | 2025 | |
| Incyte Corporation | $17.57 | 2025 | Opzelura |
| Genentech USA, INC. | $16.95 | 2024 | Erivedge |
| Galderma Laboratories, L.P. | $16.50 | 2025 | Nemluvio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.